Effect of Medicaid Coverage of Tobacco-Dependence Treatments on Smoking Cessation
Smoking cessation aids (nicotine replacement products and anti-depressant medication) have been proven to double quitting rates compared to placebo in several randomized controlled trials. But the high initial cost of cessation aids might create a financial barrier to cessation for low-income smoker...
Main Author: | Feng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2009-12-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-4601/6/12/3143/ |
Similar Items
-
Medicaid coverage for tobacco dependence treatment: Enrollee awareness and use
by: Kim A. Hayes, et al.
Published: (2021-12-01) -
Appalachian disparities in tobacco cessation treatment utilization in Medicaid
by: Amie Goodin, et al.
Published: (2020-01-01) -
Effectiveness of smoking cessation intervention supported by medicaid in Ohio
by: Haynes, Elaine F.
Published: (2003) -
Clinicians' awareness of the Affordable Care Act mandate to provide comprehensive tobacco cessation treatment for pregnant women covered by Medicaid
by: Van T. Tong, et al.
Published: (2015-01-01) -
Tobacco use by pregnant Medicaid beneficiaries: Validating a claims-based measure in Oregon
by: Jeff Luck, et al.
Published: (2020-09-01)